Abstract |
Experiences in 50 patients show that Theophyllin retard Oranienburg (280 mg theophylline) could be used as an effective bronchospasmolytic drug on conditions of mono- and combination- therapy. Advantages of this preparation are improvement of the compliance and an undisturbed night-sleep in patients. However an optimum dosage is hardly maintained in children by the present dose of a single tablet of 280 theophylline content. The effectiveness in therapy of childhood asthma could be improved by stronger sustained release effect and different doses of tablets.
|
Authors | V Sollich, R Schuster, W Thal, E Köhler, H Walther |
Journal | Kinderarztliche Praxis
(Kinderarztl Prax)
Vol. 58
Issue 1
Pg. 45-8
(Jan 1990)
ISSN: 0023-1495 [Print] Germany |
Vernacular Title | Erste Erfahrungen mit Theophyllin retard "Oranienburg" in der Asthmatherapie bei Kindern und Jugendlichen. |
PMID | 2332947
(Publication Type: English Abstract, Journal Article)
|
Chemical References |
- Delayed-Action Preparations
- Theophylline
|
Topics |
- Adolescent
- Asthma
(drug therapy)
- Child
- Delayed-Action Preparations
- Dose-Response Relationship, Drug
- Female
- Humans
- Male
- Metabolic Clearance Rate
(physiology)
- Theophylline
(administration & dosage, pharmacokinetics)
|